Kenvue Inc. (KVUE) slipped after a narrow EPS miss offset a revenue beat, but the deeper story is more nuanced. Self Care drove growth, Skin Health lagged, margins improved, and free cash flow strengthened, even as the company withheld guidance amid its Kimberly-Clark transaction.
Church & Dwight Co., Inc. (CHD) gained after a deeper-than-headline earnings beat, with stronger organic growth, margin expansion, and raised guidance. The quarter showed volume-led momentum across key brands and segments, helping support the stock’s move despite its premium valuation.
Exxonmobil Holdings Corporation (XOM) gained after a third-quarter earnings beat, but the real story is deeper than the headline. Strong refining margins powered the upside, while upstream earnings softened as Brent eased. Cash flow, dividend growth, and buybacks reinforce the stock’s fundamental backdrop.
Exelon Corporation (EXC) gained after a Q3 earnings beat, but the real story is deeper than the headline. This analysis breaks down EPS and revenue upside, rate-base growth, storm costs, financing pressure, and the utility’s long-term capital plan and transmission opportunities.
Stories from the markets, refreshed throughout the day
Space Exploration Technologies Corp. (SPCX) drops 5.5% as a broader AI and tech selloff hits high-growth names. Despite a strong earnings beat, rising analyst targets, and solid operating results, the stock remains vulnerable because its valuation is stretched and sentiment turned risk-off.
NVIDIA Corporation (NVDA) drops sharply as a broad technology selloff hits mega-cap AI names. The move appears driven by sector-wide de-risking rather than a fresh earnings miss, even as the company’s revenue growth and recent EPS beat remain strong. Investors now look to the November 18 earnings report for the next catalyst.
Taiwan Semiconductor Manufacturing Company Limited (TSM) drops as investors pull back from AI and semiconductor stocks after Intel’s weak outlook revived concerns about heavy AI spending. Despite the selloff, TSMC’s latest results remain strong, and the move appears driven more by sector sentiment than by a company-specific breakdown.
The big picture, simplified
September’s PCE report showed inflation heating up again even as consumer spending slowed and income growth weakened. Core PCE held at 3.1%, headline inflation rose to 3.6%, and markets quickly priced in a high chance of another Fed rate hike in December.
The 30-year fixed mortgage rate slipped to 7.24%, its lowest level this month, offering buyers a small boost in purchasing power. But borrowing costs remain well above last year’s levels, and housing investment is still weak, underscoring that the market has not thawed.
The U.S. economy accelerated in Q3 as real GDP rose 3.4%, powered by stronger consumer spending and a surge in AI-related business investment. Cooler price growth eased inflation fears, but the solid report still leaves the Federal Reserve on a restrictive path.
Curated lists, refreshed continuously
This countdown covers battery recycling stocks spanning integrated recovery, lithium-ion resource hubs, and water-based refining, including Li-Cycle and Aqua Metals.
A countdown of defense AI exposure across mission software, secure decision tools, autonomous systems, cyber, counter-UAS and technical services.
A seven-stock countdown spans fast-charging networks, hardware and software platforms, off-grid systems, and power-management infrastructure.
The stock behind the promotion — named, and its claims checked
Bryce Paul and Boardwalk Flock LLC are pushing “The #1 AI Crypto” under several names. We trace the Venice AI clues and test the claims behind the pitch.
Mark Skousen and The Oxford Club are pitching The Private Power Boom through The Skousen Report. We trace the clues to the company behind the private-power story.
Michael A. Robinson of Weiss Ratings is pitching the “Anthropic IPO Loophole” in Disruptors & Dominators. We trace the clues and test the AI basket.
Instant deep dives on any ticker, daily market intelligence, an AI analyst in your pocket, and portfolio tools — refreshed throughout the day.
30-day money-back guarantee · cancel anytime
Previews, flashes, and analysis
Exxonmobil Holdings Corporation (XOM) gains 0.8% after reporting earnings beats, as investors react positively to stronger-than-expected results and improved outlook signals.
Church & Dwight Co., Inc. (CHD) gains 0.8% after reporting earnings beats, as investors react positively to the company’s latest quarterly results and outlook.
IPOs & SPAC mergers on deck
Nordicus Partners Corporation (NASDAQ: NORD) is expected to list on 2026-10-30, but the company has not disclosed a price range yet. The story is less a classic IPO and more a microcap biotech holding-company setup tied to Nordic life sciences assets. Bull case: asset-backed biotech optionality; bear case: no disclosed terms, nominal revenue, and going-concern risk.
Deep Sea Minerals Corp. American Depositary Shares (NASDAQ: SEAM) is expected to list on 2026-10-30, but the price range has not been disclosed yet. The company is pitching a licensing-first way to access deep-sea mineral assets in the Cook Islands EEZ, the U.S. EEZ, and the Clarion-Clipperton Zone. Bull case: a large addressable resource story tied to critical minerals. Bear case: no revenue, widening losses, and a long, uncertain path to commercial production.
Aspen Neuroscience is expected to list on Nasdaq under the symbol ASPE on 2026-10-30, but the price range was not disclosed before pricing. The company is a clinical-stage Parkinson’s disease biotech, so the bull case is a large unmet-need market and the bear case is heavy clinical and regulatory risk.
AI deep dives across the market
Church & Dwight posted solid Q2 2026 organic growth and raised guidance, but the stock already reflects much of the good news. With shares near fair value, the report lands on a Hold.
Insmed is scaling quickly on the back of BRINSUPRI, with ARIKAYCE still contributing meaningful cash flow. The stock looks attractive for investors who can accept biotech execution risk, but valuation remains demanding.
Coinbase is expanding beyond trading into subscriptions, stablecoins, and prediction markets, but the stock already prices in a strong recovery. The report rates COIN a Hold as execution risk remains high at a rich valuation.
Bank of America’s diversified franchise, improving net interest income, and wealth-management momentum support a Buy rating. Execution risk remains, but the stock still screens attractively at 9.8x earnings.
Merck is a Buy as KEYTRUDA still drives growth, WINREVAIR is scaling fast, and the pipeline offers a path through the 2028 patent transition. The stock remains a transition story, but new products and late-stage oncology assets support the case.
Fortinet posted 20% revenue growth, 29% billings growth, and another guidance raise, but the stock still trades at a premium multiple. The report keeps a Buy rating with a fair value of $160.
Generate a deep-dive report on any ticker. AI analyst, daily market intelligence, portfolio tools.
Get Full Access →